Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Total Voting Rights

31 Mar 2011 11:19

RNS Number : 0114E
Pressure Technologies PLC
31 March 2011
 



Pressure Technologies plc ("Pressure Technologies" or the "Company")

 

Total Voting Rights

 

Pressure Technologies notifies that, as at 31 March 2011, the Company's issued share capital comprises 11,347,363 ordinary shares of 5p each. There are no ordinary shares held in Treasury. Therefore the total number of voting rights in the Company is 11,347,363.

 

The above figure of 11,347,363 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax IS PLC

Nominated Adviser and Broker

Ewan Leggat/Laura Littley

 

Tel: 0207 598 5368

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is an AIM listed, leading designer and manufacturer of speciality engineering solutions for high pressure systems serving large global markets.

 

The Group's largest subsidiary, Chesterfield Special Cylinders Limited ("CSC") designs, manufactures and offers retesting and refurbishment services for a range of speciality high pressure, seamless steel gas cylinders for global energy and defence markets. The business is conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas Limited was formed in November 2008 following the signing of a co-operation agreement with Greenlane® Biogas Limited, the world leader in biogas upgrading. This gives Pressure Technologies exclusive rights to market and manufacture Greenlane® equipment in the UK and Eire. Chesterfield BioGas provides turnkey solutions for the cleaning, storage and dispensing of biomethane for injection into the gas grid or use as a vehicle fuel.

In 2010, the Engineered Products Division was formed following the purchase of Al-Met Limited ("Al-Met") and the Hydratron group of companies ("Hydratron").

Al-Met is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, which was acquired by Pressure Technologies in February 2010. Its products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, which was established in 1985, has developed a leading edge capability in precision machining carbides, high grade stainless steels and super alloys.

Hydratron acquired on 15 October 2010, designs, manufactures and sells a range of air operated high pressure hydraulic pumps, gas boosters, power packs, hydraulic control panels and test rigs. Hydratron has sales and manufacturing companies in Altrincham, UK, and Houston, USA and a spread of third party distributors in key locations around the world. Formed in 1981, Hydratron has since established itself as a leading supplier of quality high pressure equipment to the oil and gas industries. The full range of Hydratron products may be viewed at www.hydratron.co.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAEDFDFPFEFF
Date   Source Headline
9th Aug 201312:59 pmRNSDirector/PDMR Shareholding
9th Aug 201312:09 pmRNSGrant of Share Options
5th Aug 201312:26 pmRNSHolding(s) in Company
30th Jul 20137:00 amRNSGrant of Share Options
22nd Jul 201310:32 amRNSDirector/PDMR Shareholding
1st Jul 20135:29 pmRNSHolding(s) in Company
19th Jun 20132:13 pmRNSHolding(s) in Company
11th Jun 20137:02 amRNSBoard Appointment
11th Jun 20137:00 amRNSHalf Yearly Report
23rd May 201312:01 pmRNSNotice of Results and Analyst Briefing
18th Feb 20134:36 pmRNSHolding(s) in Company
14th Feb 20132:42 pmRNSHolding(s) in Company
12th Feb 201312:03 pmRNSResult of AGM
12th Feb 201310:12 amRNSBoard Changes
12th Feb 20137:00 amRNSTrading Update
7th Feb 201312:49 pmRNSHolding(s) in Company
1st Feb 20133:37 pmRNSHolding(s) in Company
28th Jan 20139:53 amRNSHolding(s) in Company
23rd Jan 201312:09 pmRNSHolding(s) in Company
3rd Jan 20134:08 pmRNSHolding(s) in Company
24th Dec 20127:00 amRNSPublication of Report & Accounts
4th Dec 20127:00 amRNSFinal Results
26th Nov 20127:30 amRNSIssue of Equity
21st Nov 20127:30 amRNSNotice of Results and Analyst Briefing
26th Oct 20127:00 amRNSChange of Adviser
28th Sep 201211:45 amRNSTotal Voting Rights
3rd Sep 20123:17 pmRNSIssue of Equity, Director's Shareholding & TVR
30th Aug 20121:35 pmRNSHolding in Company
28th Aug 20127:00 amRNSDirector's Shareholding
17th Aug 20129:17 amRNSDirector's Shareholding
7th Aug 20127:00 amRNSGrant of Share Options
12th Jun 20127:00 amRNSInterim Results 2012
31st May 20127:00 amRNSAnalyst Briefing
30th Apr 20127:00 amRNSNotice of Results and Pre-Close Trading Statement
29th Feb 201210:42 amRNSDirector's Shareholding
23rd Feb 20123:51 pmRNSGrant of Share Options
7th Feb 20122:24 pmRNSResult of AGM 2012
7th Feb 20127:00 amRNSTrading Update
23rd Jan 20127:01 amRNSAGM and Site Tour
18th Jan 20127:00 amRNSChesterfield BioGas wins Upgrading Plant Contract
22nd Dec 20117:00 amRNSPublication of Report & Accounts
8th Dec 201110:07 amRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSPreliminary Results 2011
14th Nov 201111:58 amRNSHolding(s) in Company
14th Nov 201111:56 amRNSHolding(s) in Company
14th Nov 20117:00 amRNSAnalyst Briefing
21st Oct 20117:00 amRNSNotice of Results and Trading Update
28th Jul 201112:45 pmRNSGrant of Share Options
22nd Jul 20113:27 pmRNSDirector's Shareholding
14th Jun 20117:00 amRNSInterim Results 2011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.